🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

57,46 USD

Máx. histórico

2.925,00

12012 días

Split 1:10 del 17/11/2011

Caída desde máximo

-98,04%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-6,80%

Cierre anterior

61,65

Rango de hoy

57,24 – 61,73

Volumen hoy

1.804.873

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,85%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 1 hora
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/09/2018 17,77 18,79 17,43 18,70 +5,23% 7,65% 1.322.000
21/09/2018 18,88 18,91 17,68 17,77 -5,88% 6,52% 3.070.500
20/09/2018 18,58 18,88 18,53 18,88 +1,61% 1,88% 913.400
19/09/2018 18,80 18,98 18,13 18,58 -1,38% 4,52% 1.221.900
18/09/2018 18,16 18,95 18,05 18,84 +3,46% 4,96% 962.100
17/09/2018 18,98 18,99 17,86 18,21 -3,70% 5,95% 1.311.100
14/09/2018 18,84 19,11 18,35 18,91 +3,16% 4,01% 1.512.000
13/09/2018 19,22 19,57 18,20 18,33 -4,18% 7,13% 1.838.000
12/09/2018 19,86 20,00 18,94 19,13 -3,48% 5,34% 1.252.700
11/09/2018 20,10 21,18 19,80 19,82 -2,36% 6,87% 2.178.300
10/09/2018 19,89 20,37 19,32 20,30 +2,84% 5,28% 1.810.500
07/09/2018 19,41 20,50 18,90 19,74 +1,81% 8,24% 4.744.700
06/09/2018 18,00 22,39 18,00 19,39 +37,52% 24,39% 28.650.100
05/09/2018 15,30 15,30 13,82 14,10 -7,90% 9,67% 3.142.700
04/09/2018 14,60 15,44 14,23 15,31 +3,73% 8,29% 1.494.400
31/08/2018 14,31 14,81 14,29 14,76 +2,50% 3,63% 1.458.600
30/08/2018 14,59 14,81 14,19 14,40 -1,91% 4,22% 1.061.000
29/08/2018 14,72 14,83 14,54 14,68 -0,34% 1,97% 752.200
28/08/2018 14,79 15,10 14,67 14,73 -0,07% 2,91% 1.007.200
27/08/2018 14,93 15,04 14,55 14,74 +0,34% 3,28% 1.092.800
24/08/2018 14,42 14,78 14,42 14,69 +2,08% 2,50% 923.600
23/08/2018 14,44 14,50 14,05 14,39 +0,00% 3,12% 1.221.700
22/08/2018 14,11 14,44 14,04 14,39 +2,06% 2,83% 1.508.600
21/08/2018 14,11 14,23 13,80 14,10 -0,49% 3,05% 1.298.900
20/08/2018 14,63 14,78 13,85 14,17 -2,34% 6,36% 1.190.700
17/08/2018 14,44 14,57 13,98 14,51 +1,26% 4,09% 1.790.600
16/08/2018 14,85 15,21 13,95 14,33 -2,85% 8,48% 1.928.200
15/08/2018 16,36 16,63 14,74 14,75 -9,79% 11,55% 2.063.700
14/08/2018 16,27 16,99 16,24 16,35 +0,31% 4,61% 1.408.900
13/08/2018 16,96 17,19 16,02 16,30 -3,49% 6,88% 1.355.500